Positive results for new weight loss pill
Drugmaker Eli Lilly said Thursday that things are looking good for their latest weight loss drug that would be available as a pill. Dr. Jon LaPook reports.
Weight Loss
Timeline for weight loss-diabetes pill
A first-of-its-kind pill from Eli Lilly that addresses weight loss and diabetes is showing signs of success at its clinical trial. CBS News medical contributor Dr. Celine Gounder breaks down what to know.
New pricing for popular weight loss drug
Pharmaceutical giant Eli Lilly announced a price cut for its drug, Zepbound, for people who aren't using insurance. CBS News' Nancy Chen reports on the qualifications for the discount and what the cost reduction will be.
Drug for extreme hunger offers clues to obesity's complexity
A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their children with Prader-Willi syndrome deal with unrelenting hunger.
Fat...And Proud Of It
Jiggling thighs and flabby bellies. Many of us view extra flab as a flaw. But Mike Wallace sits down with a group of spunky women from the National Association to Aid Fat Americans who say they're "fat and proud of it," despite enduring societal pressure and scorn.
Oprah
"Oprah has arrived." That's what Mike Wallace proclaims in this profile of Oprah Winfrey, whose television talk show had just become a national sensation. Oprah describes her childhood, her struggles for acceptance in the world of TV news, and her greatest "gift" - an ability to be herself on camera.
Fat City
Morley Safer visits Durham, N.C., once the capital of the tobacco industry, but now home to a surprising new industry -- weight loss. Three major, medically supervised diet clinics are based here, treating thousands of overweight people each year.
Eating the hoodia plant
In 2004, Lesley Stahl ate hoodia, a bitter-tasting cactus-like plant that some use for weight loss.
Could weight loss drugs help prevent cancer? Here's what a new study found.
Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.
Trump won't force Medicaid to cover GLP-1s for obesity. A few states are.
Late last year, South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But access remains limited.
Patients fear losing affordable weight loss drugs
Weight loss drugs for many people may soon get a lot more expensive -- a shortage of them had actually led to lower prices. Kris Van Cleave explains how that happened and why prices could go up.
Weight loss drugs have "no end game," former FDA commissioner warns
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus."
Zepbound tops Wegovy for weight loss in study comparing the drugs
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.
Study compares weight loss drugs
A new study from the New England Journal of Medicine compares two weight loss drugs, Tirzepatide and Semaglutide. CBS News medical contributor Dr. Celine Gounder breaks down the findings.
WeightWatchers declares bankruptcy as people embrace weight loss drugs
WeightWatchers, founded in 1963, has struggled to shed debt and cope with the emergence of weight loss drugs.
Weight loss drugs could help liver disease
A study from the New England Journal of Medicine found new evidence that GLP-1 drugs used for obesity could also help people with a type of liver disease. CBS News contributor Dr. Celine Gounder explains the findings.
GLP-1 pill shows success for diabetes, weight loss, Eli Lilly says
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.
Obesity doctor touts new weight loss drug
There may soon be a new medication option for losing weight. Eli Lilly's experimental pill appears to work as well as the injected drug Ozempic to lower the weight of diabetes patients. Dr. Jon LaPook has more.
New weight loss pill found effective in trial
A new clinical trial is showing promising results for a new pill to help treat diabetes and support weight loss. CBS News chief medical correspondent Dr. Jon LaPook explains.
Can weight loss drugs help with dementia risk? Here's what studies suggest.
Popular weight loss drugs may do more than curb appetite — they may also help reduce the risk of dementia, according to new research.
Weight loss drugs could help curb dementia
Two new studies in JAMA Neurology show some diabetes and popular weight loss drugs could help to protect against dementia. CBS News medical contributor Dr. Celine Gounder joins "CBS Mornings" to explain what researchers found.
Weight loss drugs might reduce dementia risk
Two new studies suggest the class of weight loss and diabetes drugs that includes Ozempic and Wegovy have the added benefit of protecting against the development of dementia. CBS News medical contributor Dr. Céline Gounder has more.
FDA declares end to Wegovy and Ozempic shortage
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
FDA says Ozempic, Wegovy are not limited anymore
The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on whether the supply change could lead to consumers paying more.
11/15: CBS News Mornings
Israel military launches "precise and targeted operation against Hamas in a specified area" of Al-Shifa hospital in Gaza; doctors see soaring demand for weight-loss drugs.
Trump says he'll start paying for ads after pushback over taxpayer funding
Jim Bakker, who co-founded "The PTL Club" but fell into disgrace, dies at 86
Trump suggests letting Iran "take out" LA, San Diego during rally
Live
Battle with Iran-backed Houthis in Yemen tempers news on oil flow
Ex-"American Idol" contestant Caleb Flynn gets life sentence
Chicago-bound flight drops 27,000 feet, returns to London
Alleged Chinese agent makes federal court appearance
Only On CBS
Takeaways from Alito's CBS News interview
